Hot on the heels of a $150 million fundraise, Atsena Therapeutics is back with early-stage data for the company’s eye disease ...

Pacibekitug, an antibody targeting interleukin-6, hit the primary endpoint in the phase 2 Tranquility trial by sharply ...

Apellis Pharmaceuticals focuses on creating medicines targeting eye diseases and rare neurological diseases. Read why I rate ...

Discover the charm of classic woodworking that can elevate any home to timeless elegance! 🏡✨ From intricate moldings to stunning built-ins, these features are the perfect blend of craftsmanship and ...

With lung cancer rates among non-smokers rising, especially young East Asian women, a new study released Monday is touting ...

Being spliced on to Regeneron will free the genetic testing company from its fatal dependence on sporadic revenue ...

The conversation then shifts to the recent appointment of Ross McElroy as CEO of Apollo Silver. Andy highlights Ross' ...

The order is expected to impact innovator companies, which may spend less on research in an effort to cut costs, analysts ...

Living Nostradamus’, Athos Salomé, has made a seriously eerie war prediction that he claims is just a matter of ‘seconds away ...

Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in tissue-targeted AAV gene therapy, today announces the publication of a seminal research manuscript in Nature Communications: ...

As Memorial Day weekend marks the unofficial start to summer, the Surfrider Foundation is releasing its annual Clean Water Report to help keep you and your family safe at the beach. This comprehensive ...

The move raises privacy concerns as the drugmaker takes control of the genetic data of millions of clients of the ...